Valuation : Getinge AB

Market Cap 66.24B 6.91B 5.96B 5.6B 5.1B 9.6B 655B 9.65B 25.78B 333B 25.93B 25.36B 1,105B P/E 2026 *
21.2x
P/E 2027 * 19.1x
Enterprise Value 74.76B 7.79B 6.72B 6.32B 5.76B 10.83B 740B 10.89B 29.1B 376B 29.26B 28.63B 1,248B EV / Sales 2026 *
2.12x
EV / Sales 2027 * 1.95x
Free-Float
79.13%
Yield 2026 *
2.16%
Yield 2027 * 2.32%
1 week-0.59%
1 month+1.76%
3 months+24.45%
6 months+15.26%
Current year+8.40%
1 week 21.84
Extreme 21.84
22.28
1 month 21.52
Extreme 21.52
22.28
3 years 14.2
Extreme 14.2
22.28
5 years 14.2
Extreme 14.2
43.02
10 years 0
Extreme 0
43.02
Manager TitleAgeSince
Chief Executive Officer 54 01/05/2017
Director of Finance/CFO 48 31/03/2024
Compliance Officer 47 01/10/2020
Director TitleAgeSince
Chairman 65 23/04/2019
Chairman 75 -
Director/Board Member 70 01/01/2007
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-0.59%+16.67%+36.70% 6.93B
-0.16%-0.55%+19.70%+22.13% 12.73B
-0.29%-0.73%+17.37%+27.76% 6.93B
+0.72%-6.25%+49.72%+27.97% 6.26B
+10.66%+18.50% - - 5.69B
+1.85%-3.43%-12.20%+46.03% 5.08B
+0.65%+0.62%-30.15%-22.88% 3.85B
-1.53%-1.36%+42.58%-22.03% 2.06B
+0.83%+11.99%-13.16%+134.36% 1.78B
+2.08%+2.57%+51.33%-13.08% 1.6B
Average +1.71%+1.20%+15.76%+26.33% 5.11B
Weighted average by Cap. +1.71%-0.18%+16.23%+25.89%

Financials

2026 *2027 *
Net sales 35.22B 3.67B 3.17B 2.98B 2.71B 5.1B 349B 5.13B 13.71B 177B 13.79B 13.49B 588B 37.17B 3.88B 3.34B 3.14B 2.86B 5.39B 368B 5.42B 14.47B 187B 14.55B 14.23B 620B
Net income 3.14B 327M 282M 266M 242M 455M 31.05B 457M 1.22B 15.8B 1.23B 1.2B 52.38B 3.46B 361M 312M 293M 267M 502M 34.28B 505M 1.35B 17.44B 1.36B 1.33B 57.82B
Net Debt 8.52B 889M 766M 721M 657M 1.24B 84.33B 1.24B 3.32B 42.9B 3.34B 3.26B 142B 6.31B 658M 568M 534M 486M 915M 62.44B 919M 2.46B 31.76B 2.47B 2.42B 105B
Logo Getinge AB
Getinge AB is a Sweden-based company operating within healthcare sector. The Company provides hospitals and Life Science institutions with products and solutions aimed at improving clinical outcomes and optimizing workflows. The Company’s reporting segments have the following activities: Acute Care Therapies develops solutions for life-sustaining care in acute health conditions. Life Science offers a comprehensive range of equipment, technical expertise and prevention consultation contamination in pharmaceutical production, biomedical research, production of medical equipment and in various laboratory applications. Surgical Workflows offers products and services for the effective disinfection and sterilization of instruments used in operations, operating tables and others hardware for operating rooms and advanced IT systems for efficient and secure workflows in hospitals.
Employees
-
Date Price Change
01/09/26 21.94 0.00%
31/08/26 €21.94 -1.26%
28/08/26 €22.22 +0.54%
27/08/26 €22.10 +0.23%
26/08/26 €22.05 +0.05%
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
243.90SEK
Average target price
240.11SEK
Spread / Average Target
-1.55%

Quarterly revenue - Rate of surprise